ResearcherOregon Health & Science UniversityActive in the last 2 years

Luis Francisco Diaz

ORCID-verified (high confidence, 0.95), identity_conf@1As of 6 November 2026

Matched on ORCID iD 0000-0002-7744-502X; OpenAlex author ID A5032329007; NIH RePORTER profile ID 16073972. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 1
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2024: 1 paper · 2025: 1 paper · 2026: 1 grant

Papers 2

Author Correction: Autotaxin-lysolipid signaling suppresses a CCL11-eosinophil axis to promote pancreatic cancer progression. Co-author DOI 10.1038/s43018-025-01035-9 ↗
Autotaxin-lysolipid signaling suppresses a CCL11-eosinophil axis to promote pancreatic cancer progression. Co-author DOI 10.1038/s43018-023-00703-y ↗

Grants 1

Defining the role of the mitochondrial protein, GOT2, in pancreatic cancer metastasis and epigenetic dysregulation F31CA288079 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Sohinee Bhattacharyya · 2 shared papers, 2024–2025 · strength 0.45
- Paper Author Correction: Autotaxin-lysolipid signaling suppresses a CCL11-eosinophil axis to promote pancreatic cancer progre… DOI 10.1038/s43018-025-01035-9 ↗
- Paper Autotaxin-lysolipid signaling suppresses a CCL11-eosinophil axis to promote pancreatic cancer progression. DOI 10.1038/s43018-023-00703-y ↗
Terry K. Morgan · 2 shared papers, 2024–2025 · strength 0.45
- Paper Author Correction: Autotaxin-lysolipid signaling suppresses a CCL11-eosinophil axis to promote pancreatic cancer progre… DOI 10.1038/s43018-025-01035-9 ↗
- Paper Autotaxin-lysolipid signaling suppresses a CCL11-eosinophil axis to promote pancreatic cancer progression. DOI 10.1038/s43018-023-00703-y ↗
Holly Sandborg · 2 shared papers, 2024–2025 · strength 0.45
- Paper Author Correction: Autotaxin-lysolipid signaling suppresses a CCL11-eosinophil axis to promote pancreatic cancer progre… DOI 10.1038/s43018-025-01035-9 ↗
- Paper Autotaxin-lysolipid signaling suppresses a CCL11-eosinophil axis to promote pancreatic cancer progression. DOI 10.1038/s43018-023-00703-y ↗
Mara H. Sherman · 2 shared papers, 2024–2025 · strength 0.45
- Paper Author Correction: Autotaxin-lysolipid signaling suppresses a CCL11-eosinophil axis to promote pancreatic cancer progre… DOI 10.1038/s43018-025-01035-9 ↗
- Paper Autotaxin-lysolipid signaling suppresses a CCL11-eosinophil axis to promote pancreatic cancer progression. DOI 10.1038/s43018-023-00703-y ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.